Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study
Wong, Raymond SM, Brynes, Russell K, Orazi, Attilio, Aziz, Zeba, Melikyan, Anait L., Salama, Abdulgabar, Arikan, Ozlem Ocak, Maier, Joan, Shamsi, Tahir
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Occurrence and Management of Cataracts in Adult Patients (pts) with Chronic Immune Thrombocytopenia (cITP) during Long-Term Treatment with Eltrombopag (EPAG): Results from the Extend Study
Wong, Raymond SM, Khelif, Abderrahim, Salama, Abdulgabar, Saleh, Mansoor N., Arikan, Ozlem Ocak, Quebe-Fehling, Erhard, Bussel, James B.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Eltrombopag and Cyclosporine as First-Line Therapy in Patients with Severe Acquired Aplastic Anemia: A Two-part, 5-year, Single-Arm, Multicenter, Open-label, Phase 2 Trial (SOAR)
Scheinberg, Phillip, Maier, Joan, Arikan, Ozlem Ocak, Finelli, Carlo, Jang, Junho
Published in Clinical lymphoma, myeloma and leukemia (01.09.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2017)
Get full text
Journal Article
Clinical effectiveness of Everolimus and Exemestane in advanced breast cancer patients from Asia and Africa: First efficacy and updated safety results from the phase IIIb EVEREXES study
Im, Young-Hyuck, Uslu, Ruchan, Lee, Keun Seok, Nagarkar, Rajnish Vasant, Sohn, Joohyuk, Sevinc, Alper, Altundag, Kadri, Chang, Yuan-Ching, Abdel-Razeq, Hikmat, Im, Seock-Ah, Jeong, Joon, Park, Ho Yong, Arpornwirat, Wichit, Bastick, Patricia A., Le, Tuan Anh, Ocak Arikan, Ozlem, Xue, Hong-Ling, Canatar, Aycin, Valenti, Roberta, Kim, Sung-Bae
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
International, expanded access program of everolimus in patients with metastatic renal cell carcinoma (mRCC) who progressed after previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy (VEGFr-TKI): Subanalysis from emerging growth market (EGM) countries
Lee, Se-Hoon, Buyukberber, Suleyman, Ou, Yen-Chuan, Shapiro, Jeremy David, Panneerselvam, Ashok, Ocak Arikan, Ozlem, Xue, Hong-Ling, Rusakov, Igor
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article